Two major pharmaceutical companies are currently developing therapeutic candidates for potential treatment for Ebola disease caused by the Bundibugyo virus. The virus is responsible for the ongoing outbreak in Democratic Republic of Congo (DRC). However, Doctors Without Borders/Médecins Sans Frontières (MSF) is calling for greater transparency on their development, warning that past experience has shown […]
Democratic Republic of Congo: Ebola disease clinical trials must result in equitable access to treatment